Based on most recent patient findings, select the likely presentation (Cellulitis or Impetigo) for each intervention

• Administer antipyretic as prescribed: Child B presents with a fever of 38.6; antipyretics help manage elevated temperature and patient discomfort. In cellulitis, systemic involvement is often more pronounced, requiring careful monitoring of response to antipyretics. • Administer oxygen as prescribed: Child B shows hypoxia (SpO₂ 87%) and worsening systemic symptoms such as tachycardia and lethargy, indicating possible sepsis from severe cellulitis. Oxygen therapy is critical to maintain adequate tissue oxygenation. In contrast, Child A with impetigo is alert with normal vitals, making oxygen unnecessary. • Administer IV normal saline bolus as prescribed: The client demonstrates hypotension, tachycardia, delayed capillary refill, and decreased perfusion, suggesting hypovolemia or early septic shock from cellulitis. IV fluids help restore circulating volume and improve perfusion. Child A’s vital signs are stable, and IV fluids are not indicated for uncomplicated impetigo. • Prep the patient for discharge: Child A is stable, alert, vital signs normal, and responding to topical Bactroban therapy. Discharge is appropriate with home care instructions. Cellulitis in Child B is worsening, so discharge would be unsafe. • Offer patient Pedialyte by mouth: Oral hydration is suitable for a stable child with impetigo to maintain fluid balance. Child B with systemic symptoms and hypotension requires IV fluids rather than oral rehydration. • Call provider with update on vital signs and patient status: Child B’s worsening vitals, hypoxia, lethargy, and expanding erythema indicate a need for urgent provider notification to adjust treatment and escalate care. Impetigo in Child A is stable, and provider notification is not urgent. • Prepare broad-spectrum IV antibiotics: Severe cellulitis with systemic involvement and rapid progression requires IV antibiotic therapy to control infection. Child A’s impetigo responds to topical antibiotics and does not require IV antibiotics.